TeraXion, a leader in optical components and modules, is pleased to announce the acquisition of COGO Optronics Canadian Subsidiary along with critical intellectual property assets. Woodside Capital Partners acted as the exclusive advisers to this transaction.
Québec City, Canada, August 13, 2012 - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its V.P., Medicinal Chemistry, Matthias Gerlach, PhD, will be making a poster presentation on preclinical results for the Company's novel orally active anticancer PI3K/Erk 1/2 inhibitor, AEZS-136, during the 244th National Meeting of the American Chemistry Society which will be held August 19-23, 2012, in Philadelphia.
B-TEMIA and its dermoskeleton have been selected to showcase at the World Future Society’s Conference: World Future 2012: Dream, Design, Develop and Deliver held in Toronto from July 27-29.
Medicago Successfully Completes the Production of More Than Ten Million Doses of H1N1 VLP Influenza Vaccine in One Month.
TeraXion, a leading manufacturer of optical components and modules for high-speed networks, announces today the agreement concluded with TeraComm and Ward/Davis Associates, adding them as sales representatives in the United States. This addition strengthens TeraXion’s international presence and complements an already vast international distribution channel.
"We are pleased to announce that our initial research collaboration with this top 10 global pharma company has been completed successfully."